Since its founding, HKUMed has played a pivotal role in the treatment and control of disease outbreaks in Hong Kong. This expertise has only grown over the past 135 years, with researchers across Schools and Departments becoming global leaders in epidemiology and virology.
This foundation, alongside strong relationships with clinicians, scientists and public health authorities in mainland China meant the Faculty’s scientists produced some of the earliest research into what we now know as SARS-CoV-2, the virus behind the COVID-19 pandemic.
Our scientists from the School of Public Health brought to light the epidemiological dynamics of the novel virus by analysing its transmission data, thereby enabling HKUMed in issuing a warning to the global community over the risk to public health.
Our clinician-scientists from the Department of Microbiology was also able to confirm person-to-person transmission of SARS-CoV-2 through a variety of imaging and empirical investigation methods. Their findings had a major impact on control strategies to limit the spread of the virus.
Our scientists and clinicians have continued to lead the study of COVID-19, from diagnostics to pathogenesis, disease models, treatment and vaccines.
自創院以來，港大醫學院一直在本港的疫症治療和防控中，擔當不可或缺的關鍵角色。我們各個學院及學系的研究人員，無論在流感及冠狀病毒的研究中皆領先群倫，多年來多項突破性研究亦奠定港大醫學院在新發傳染病範疇中的世界領導地位。
這穩健的根基，加上我們與臨床醫護、科學家與及內地公共衞生機關的緊密合作，讓研究學者們得以揭開新冠肺炎的病毒源——2019冠狀病毒的神秘面紗，並發表疫症最早期的研究。
我們的公共衞生學院，以數據推算病毒的傳播趨勢，並向國際社會發出大流行預警。
此外，微生物學系的臨床學者，亦從多方面研究新冠病毒。重點的發現包括確定了新冠病毒會人傳人，對往後的疫情防控措施有重大的影響。
我們的科學家，和臨床學者將繼續致力各項關於新冠肺炎的研究，從診斷、發病機制、感染模型、治療、以至疫苗，希望為人類在疫症中帶來新曙光。
